Published in Cancer Weekly, January 29th, 2002
Small cell lung cancer is both chemo- and radiosensitive. The brain is a common site of metastases for patients with this disease, but the blood-brain barrier often prevents chemotherapeutic agents from reaching tumoricidal levels. Therefore, it has been suggested that patients with complete remission from small-cell lung cancer might benefit from prophylactic cranial irradiation.
In research conducted in Canada under the leadership of T. H. Patricia Tai, MB, BS, an oncologist in the Department...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.